Corrigendum to The polymorphism XRCC1 Arg194Trp and 8-hydroxydeoxyguanosine increased susceptibility to arsenic-related renal cell carcinoma. Toxicology and Applied Pharmacology 332 (2017) 1–7 (S0041008X17303095) (10.1016/j.taap.2017.07.012))

Yu Mei Hsueh, Ying Chin Lin, Wei Jen Chen, Chao Yuan Huang, Horng Sheng Shiue, Yeong Shiau Pu, Chi Hung Chen, Chien Tien Su*

*Corresponding author for this work

Research output: Contribution to journal › Comment/debate

Fingerprint

Dive into the research topics of 'Corrigendum to The polymorphism XRCC1 Arg194Trp and 8-hydroxydeoxyguanosine increased susceptibility to arsenic-related renal cell carcinoma. Toxicology and Applied Pharmacology 332 (2017) 1–7 (S0041008X17303095) (10.1016/j.taap.2017.07.012))'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science